Human medicines European public assessment report (EPAR): Foclivia, pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted), Influenza, Human;Immunization;Disease Outbreaks, Date of authorisation: 18/10/2009, Revision: 13, Status: Au

Human medicines European public assessment report (EPAR): Foclivia, pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted), Influenza, Human;Immunization;Disease Outbreaks, Date of authorisation: 18/10/2009, Revision: 13, Status: Authorised

Clinical Trials Information System (CTIS) bitesize talk: How to submit a transitional trial in CTIS, Online, 15:30 - 17:00 Amsterdam time (CEST), from 21/06/2023 to 21/06/2023

Clinical Trials Information System (CTIS) bitesize talk: How to submit a transitional trial in CTIS, Online, 15:30 - 17:00 Amsterdam time (CEST), from 21/06/2023 to 21/06/2023

Clinical Trials Information System (CTIS): Walk-in clinic - June 2023, Online, 16:00 - 17:00 Amsterdam time (CEST), from 14/06/2023 to 14/06/2023

Clinical Trials Information System (CTIS): Walk-in clinic - June 2023, Online, 16:00 - 17:00 Amsterdam time (CEST), from 14/06/2023 to 14/06/2023

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness